-
2
-
-
0019991766
-
Pharmakokinetic Properties of Noscapine
-
Dahlstrom, B.; Mellstrand, T.; Lofdahl, C.-G.; Johansson, M. Pharmakokinetic Properties of Noscapine Eur. J. Clin. Pharmacol. 1982, 22, 535-539
-
(1982)
Eur. J. Clin. Pharmacol.
, vol.22
, pp. 535-539
-
-
Dahlstrom, B.1
Mellstrand, T.2
Lofdahl, C.-G.3
Johansson, M.4
-
3
-
-
17444429486
-
Synergists and antagonists of mitotic poisons
-
Lettre, H. Synergists and antagonists of mitotic poisons Ann. N.Y. Acad. Sci. 1954, 58, 1264-1275
-
(1954)
Ann. N.Y. Acad. Sci.
, vol.58
, pp. 1264-1275
-
-
Lettre, H.1
-
4
-
-
0006164865
-
Narcotin, ein mitosegift (Narcotine, a mitotic poison)
-
Lettre, H.; Albrecht, M. Narcotin, ein mitosegift (Narcotine, a mitotic poison) Naturwissenschaften 1942, 30, 184-185
-
(1942)
Naturwissenschaften
, vol.30
, pp. 184-185
-
-
Lettre, H.1
Albrecht, M.2
-
5
-
-
0032539565
-
Opium Alkaloid Noscapine Is an Antitumor Agent That Arrests Metaphase and Induces Apoptosis in Dividing Cells
-
Ye, K.; Ke, Y.; Keshava, N.; Shanks, J.; Kapp, J. A.; Tekmal, R. R.; Petros, J.; Joshi, H. C. Opium Alkaloid Noscapine Is an Antitumor Agent That Arrests Metaphase and Induces Apoptosis in Dividing Cells Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 1601-1606
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 1601-1606
-
-
Ye, K.1
Ke, Y.2
Keshava, N.3
Shanks, J.4
Kapp, J.A.5
Tekmal, R.R.6
Petros, J.7
Joshi, H.C.8
-
6
-
-
0034491250
-
Noscapine and Analogues as Potential Chemotherapeutic Agents
-
Joshi, H. C.; Zhou, J. Noscapine and Analogues as Potential Chemotherapeutic Agents Drug News Perspect. 2000, 13 (9) 543-546
-
(2000)
Drug News Perspect.
, vol.13
, Issue.9
, pp. 543-546
-
-
Joshi, H.C.1
Zhou, J.2
-
7
-
-
0033928547
-
Noscapine Inhibits Tumor Growth with Little Toxicity to Normal Tissues or Inhibition of Immune Responses
-
Ke, Y.; Ye, K.; Grossniklaus, H. E.; Archer, D. R.; Joshi, H. C.; Kapp, J. A. Noscapine Inhibits Tumor Growth with Little Toxicity to Normal Tissues or Inhibition of Immune Responses Cancer Immunol. Immunother. 2000, 49, 217-225
-
(2000)
Cancer Immunol. Immunother.
, vol.49
, pp. 217-225
-
-
Ke, Y.1
Ye, K.2
Grossniklaus, H.E.3
Archer, D.R.4
Joshi, H.C.5
Kapp, J.A.6
-
8
-
-
0037099621
-
Noscapine Alters Microtubule Dynamics in Living Cells and Inhibits the Progression of Melanoma
-
Landen, J. W.; Lang, R.; McMahon, S. J.; Rusan, N. M.; Yvon, A.-M.; Adams, A. W.; Sorcinelli, M. D.; Campbell, R.; Bonaccorsi, P.; Ansel, J. C.; Archer, D. R.; Wadsworth, P.; Armstrong, C. A.; Joshi, H. C. Noscapine Alters Microtubule Dynamics in Living Cells and Inhibits the Progression of Melanoma Cancer Res. 2002, 62, 4109-4114
-
(2002)
Cancer Res.
, vol.62
, pp. 4109-4114
-
-
Landen, J.W.1
Lang, R.2
McMahon, S.J.3
Rusan, N.M.4
Yvon, A.-M.5
Adams, A.W.6
Sorcinelli, M.D.7
Campbell, R.8
Bonaccorsi, P.9
Ansel, J.C.10
Archer, D.R.11
Wadsworth, P.12
Armstrong, C.A.13
Joshi, H.C.14
-
9
-
-
33645740451
-
Rational design of the microtubule-targeting anti-breast cancer drug EM015
-
Aneja, R.; Lopus, M.; Zhou, J.; Vangapandu, S. N.; Ghaleb, A.; Yao, J.; Nettles, J. H.; Zhou, B.; Gupta, M.; Panda, D.; Chandra, R.; Joshi, H. C. Rational design of the microtubule-targeting anti-breast cancer drug EM015 Cancer Res. 2006, 66, 3782-3791
-
(2006)
Cancer Res.
, vol.66
, pp. 3782-3791
-
-
Aneja, R.1
Lopus, M.2
Zhou, J.3
Vangapandu, S.N.4
Ghaleb, A.5
Yao, J.6
Nettles, J.H.7
Zhou, B.8
Gupta, M.9
Panda, D.10
Chandra, R.11
Joshi, H.C.12
-
10
-
-
84863267059
-
-
Cougar Biotechnology, Inc. Raritan, NJ, December 21, (accessed September 8, 2008).
-
Cougar Biotechnology Initiates Phase I Trial for CB3304 (Noscapine); Cougar Biotechnology, Inc.: Raritan, NJ, December 21, 2007; http://www. cougarbiotechnology.com/docs/122107CougarCB3304PhaseITrialInitiation.pdf (accessed September 8, 2008).
-
(2007)
Cougar Biotechnology Initiates Phase i Trial for CB3304 (Noscapine)
-
-
-
11
-
-
20944431721
-
Discovery of S-Phase Arresting Agents Derived from Noscapine
-
Anderson, J. T.; Ting, A. E.; Boozer, S.; Brunden, K. R.; Danzig, J.; Dent, T.; Harrington, J. J.; Murphy, S. M.; Perry, R.; Raber, A.; Rundlett, S. E.; Wang, J.; Wang, N.; Bennani, Y. L. Discovery of S-Phase Arresting Agents Derived from Noscapine J. Med. Chem. 2005, 48, 2756-2758
-
(2005)
J. Med. Chem.
, vol.48
, pp. 2756-2758
-
-
Anderson, J.T.1
Ting, A.E.2
Boozer, S.3
Brunden, K.R.4
Danzig, J.5
Dent, T.6
Harrington, J.J.7
Murphy, S.M.8
Perry, R.9
Raber, A.10
Rundlett, S.E.11
Wang, J.12
Wang, N.13
Bennani, Y.L.14
-
12
-
-
28544446298
-
Identification of novel and improved antimitotic agents derived from noscapine
-
Anderson, J. T.; Ting, A. E.; Boozer, S.; Brunden, K. R.; Crumrine, C.; Danzig, J.; Dent, T.; Faga, L.; Harrington, J. J.; Hodnick, W. F.; Murphy, S. M.; Pawlowski, G.; Perry, R.; Raber, A.; Rundlett, S. E.; Stricker-Krongrad, A.; Wang, J.; Bennani, Y. L. Identification of novel and improved antimitotic agents derived from noscapine J. Med. Chem. 2005, 48, 7096-7098
-
(2005)
J. Med. Chem.
, vol.48
, pp. 7096-7098
-
-
Anderson, J.T.1
Ting, A.E.2
Boozer, S.3
Brunden, K.R.4
Crumrine, C.5
Danzig, J.6
Dent, T.7
Faga, L.8
Harrington, J.J.9
Hodnick, W.F.10
Murphy, S.M.11
Pawlowski, G.12
Perry, R.13
Raber, A.14
Rundlett, S.E.15
Stricker-Krongrad, A.16
Wang, J.17
Bennani, Y.L.18
-
14
-
-
1642401199
-
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
-
Ravelli, R. B.; Gigant, B.; Curmi, P. A.; Jourdain, I.; Lachkar, S.; Sobel, A.; Knossow, M. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain Nature 2004, 428, 198-202
-
(2004)
Nature
, vol.428
, pp. 198-202
-
-
Ravelli, R.B.1
Gigant, B.2
Curmi, P.A.3
Jourdain, I.4
Lachkar, S.5
Sobel, A.6
Knossow, M.7
-
15
-
-
0036240628
-
Interaction of nocodazole with tubulin isotypes
-
Xu, K.; Schwarz, P. M.; Luduena, R. F. Interaction of nocodazole with tubulin isotypes Drug Dev. Res. 2002, 55, 91-96
-
(2002)
Drug Dev. Res.
, vol.55
, pp. 91-96
-
-
Xu, K.1
Schwarz, P.M.2
Luduena, R.F.3
|